Frazier Management’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Frazier Management’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,668,570	Closed	-$106M	–	7
2016 Q3	$106M	Hold	2,668,570	–	–	52.04%	1
2016 Q2	$33.5M	Hold	2,668,570	–	–	26.73%	1
2016 Q1	$21.8M	Hold	2,668,570	–	–	13.44%	4
2015 Q4	$26.8M	Buy	+2,668,570	New	+$27.7M	11.21%	5

Frazier Management's TBRA Position: Q4 2016 in Review

Frazier Management sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 2,668,570 shares — an estimated $106M sold.

Frazier Management first reported a position in TBRA in Q4 2015 and held it in 4 quarters. The position peaked at $106M in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

Frazier Management reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Frazier Management sold 2,668,570 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $106M.
Frazier Management first reported a position in Tobira Therapeutics, Inc. Common Stock in Q4 2015 and held it in 4 quarters.
Frazier Management's Tobira Therapeutics, Inc. Common Stock position peaked at $106M in Q3 2016.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Frazier Management's 13F filing for Q4 2016, filed 13 Feb 2017.